GSTP1 and prostate carcinoma: Glutathione S-Transferase P1 (GSTP1) and Retinoic Acid Receptor 2 (RARβ2) were selected as markers given that their methylation has been previously shown to be more prevalent in prostate cancer cells [6-8].